Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study

Table 3

Correlation between the level of CXCL16, endocan, and H-FABP with the clinical laboratory characteristics of respondents.

Variables	CXCL16		H-FABP		Endocan
	r		r		r
Age, years	0.04	0.51	0.18	0.007	0.13	0.046
Sex	0.19	0.004	0.09	0.160	0.06	0.382
BMI, kg/m^2	0.01	0.88	0.15	0.023	0.03	0.635
Waist length, cm	0.02	0.73	0.23	≤0.001	0.07	0.304
SBP, mm Hg	0.04	0.51	0.11	0.112	0.11	0.110
DBP, mm Hg	0.05	0.41	0.09	0.153	0.11	0.113
Glucose, mmol/l	0.01	0.81	0.31	≤0.001	0.09	0.194
Cholesterol, mmol/l	0.05	0.39	0.08	0.228	0.02	0.110
Smoking	−0.01	0.86	0.02	0.723	0.09	0.180

Correlation is significant at 0.05 (two-tailed); correlation is significant at 0.01 (two-tailed).